HAVE A NICE WEEKEND. GO
A SCATTERSHOT LOOK AT THE NEW VARIANT BA-2: MAYBE IT’S SLOWING DOWN!
(J. Harris: This is a summary of several articles by Becker, is easy to read, and should be. It has been found in the US.)
Russia Is In The Midst Of A Huge Omicron-Driven Surge. (New York Times)
As Russia commands the world’s attention with a military buildup around Ukraine, it faces a stubborn domestic challenge: the coronavirus. On Friday, the country reported a daily record of 200,000 new coronavirus cases, as the highly transmissible Omicron variant sweeps across the remote parts of the vast country. Though deaths in Russia are off their November peak, the surge has served as a reminder of the vulnerability of Russia’s vaccine-skeptical population. Omicron, which has also driven case counts up to extraordinary levels in many other European countries, began spreading across Russia in the middle of January, quickly becoming dominant in Moscow and other urban centers. The country recorded more than 170,000 cases over the past week, or 122 cases per 100,000 people, according to the Center for Systems Science and Engineering at Johns Hopkins University.
USE OF ACE INHIBITORS FOR BLOOD PRESSURE CONTROL AND COVID PANDEMIC
(J. Harri: There is no conventionally obtained information that ACE inhibitors help or hurt patients with Covid. Many studies are in progress. I’ll watch. The attached 2021 articles have many references that you can evaluate)
ACE inhibitors and ARBs were not associated with COVID‐19 hospitalization or mortality. Despite early evidence for a potential association between ACE inhibitors and severe COVID‐19 prevention in older individuals, the inconsistency of this observation in recent data argues against a role for prophylaxis.
”…In a population of almost 2 million hypertensive patients (ACE inhibitors: 566 023; ARB: 958 227; CCB: 358 306) followed for 16 weeks, 2338 were hospitalized and 526 died or were intubated for COVID-19. ACE inhibitors and ARBs were associated with a lower risk of COVID-19 hospitalization compared with CCBs (hazard ratio, 0.74 [95% CI, 0.65-0.83] and 0.84 [0.76-0.93], respectively) and a lower risk of intubation/death. Risks were slightly lower for ACE inhibitor users than for ARB users. This large observational study may suggest a lower COVID-19 risk in hypertensive patients treated over a long period with ACE inhibitors or ARBs compared with CCBs. These results, if confirmed, tend to contradict previous hypotheses and raise new hypotheses…”
KF 94 MASKS:
J. Harris: We looked at improved masks a few weeks ago. I subsequently tried the KF94 (not 95) and it is now my mask of choice because it fits tightly but comfortably and has SPACE in front of the nose and mouth.)
”KF94 masks are high-quality masks made in South Korea that are often described as being more comfortable than typical respirators, The New York Times reported Feb. 10.
Here are five things to know about them:
1. KF94 stands for “Korean filter” and offers 94 percent filtration.
2. The masks were developed for public use and are available in adult and child sizes, unlike the respirator-style mask approved in the U.S.
3. They can be worn for about 40 hours as long as they remain clean and continue to fit snugly on the face.
4. The design creates more space between the mask and the mouth, leading some wearers to say they’re more comfortable than typical respirators.”
5. There are seemingly fewer KF94 counterfeit masks on the market.
AND LAST BUT NOT LEASED:
I’m getting tired of being part of a major historical event
Don’t be worried about your smartphone or TV spying on you. Your vacuum cleaner has been collecting dirt on you for years
GIVE US YOUR FEEDBACK. CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.
P.O. Box 721